Jesmond Dalli, Professor in Molecular Pharmacology at QMUL, said: “The study is important because it identifies for the first time the loss of RvT4 production as a potential new cause of blood vessel inflammation in the context of arthritis, offering a mechanistic explanation on the cause of this important disease in rheumatoid arthritis patients.”